The quest for a tumor suppressor gene phenotype.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Current molecular medicine

• Publication date

  2003-10-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1566524033479500PMID 14601636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of BRCA1 expression in sporadic male breast carcinoma

  2004cited by this paper
• Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer

  2002cited by this paper
• Frequency of BRCA1 dysfunction in ovarian cancer.

  2002cited by this paper
• Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus

  2002cited by this paper
• Immunohistochemical study of the expression of cell cycle regulating proteins at different stages of bladder cancer

  2002cited by this paper
• High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.

  2002cited by this paper
• Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence

  2002cited by this paper
• Heterogeneity of Ovarian Cancer: Relationships Among Histological Group, Stage of Disease, Tumor Markers, Patient Characteristics, and Survival

  2002cited by this paper
• Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.

  2002cited by this paper
• Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours

  2002cited by this paper
• Alterations of the p16ink4a gene in resected nonsmall cell lung tumors and exfoliated cells within sputum

  2002cited by this paper
• Considerations when analyzing the methylation status of PTEN tumor suppressor gene.

  2002cited by this paper
• Reduced expression of PTEN correlates with breast cancer progression.

  2002cited by this paper
• Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1

  2002cited by this paper
• Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line.

  2002cited by this paper
• Mapping of nasopharyngeal carcinoma tumor‐suppressive activity to a 1.8‐megabase region of chromosome band 11q13

  2002cited by this paper
• Reduced PTEN expression in gastric cancer and in the gastric mucosa of gastric cancer relatives

  2002cited by this paper
• Heterogeneous methylation and deletion patterns of the INK4a/ARF locus within prostate carcinomas.

  2002cited by this paper
• Tumour suppressor genes in sporadic epithelial ovarian cancer.

  2002cited by this paper
• Promoter Methylation Status of the DNA Repair Genes hMLH1 and MGMT in Gastric Carcinoma and Metaplastic Mucosa

  2002cited by this paper
• DNA methylation patterns and epigenetic memory.

  2002cited by this paper
• Functional evidence for the presence of tumor suppressor gene on chromosome 10p15 in human prostate cancers

  2001cited by this paper
• [Molecular abnormalities in epithelial ovarian tumors: present and future].

  2001cited by this paper
• Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes.

  2001cited by this paper
• Animal models of tumor-suppressor genes.

  2001cited by this paper
• Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: clinicopathologic correlation and survival analysis.

  2001cited by this paper
• Evidence for a putative senescence gene locus within the chromosomal region 10p14-p15.

  2001cited by this paper
• TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

  2001cited by this paper
• The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth.

  2001cited by this paper
• A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepatocellular carcinoma.

  2001cited by this paper
• Functional evidence for a telomerase repressor gene on human chromosome 10p15.1

  2001cited by this paper
• Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix.

  2001cited by this paper
• Mutation of the ST7 tumor suppressor gene on 7q31.1 is rare in breast, ovarian and colorectal cancers

  2001cited by this paper
• Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death.

  2001cited by this paper
• DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis.

  2001cited by this paper
• Cancer genetics: from Boveri and Mendel to microarrays

  2001cited by this paper
• Heterocyclic amine induced apoptotic response in the human lymphoblastoid cell line TK6 is linked to mismatch repair status.

  2001cited by this paper
• Growth inhibition due to complementation of transforming growth factor‐β receptor type II‐defect by human chromosome 3 transfer in human colorectal carcinoma cells

  2001cited by this paper
• BRCA1 and BRCA2 and the genetics of breast and ovarian cancer.

  2001cited by this paper
• The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation

  2001cited by this paper
• Cancer genetics

  2001cited by this paper
• Functional analysis of CpG methylation in the BRCA1 promoter region

  2001cited by this paper
• Mutational and functional analyses reveal that ST7 is a highly conserved tumor-suppressor gene on human chromosome 7q31

  2001cited by this paper
• Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.

  2001cited by this paper
• Mechanisms underlying losses of heterozygosity in human colorectal cancers

  2001cited by this paper
• Clinical significance of molecular genetic changes in sporadic invasive pituitary adenomas

  2001cited by this paper
• Ever since Knudson.

  2001cited by this paper
• Absence of ST7 mutations in tumor-derived cell lines and tumors

  2001cited by this paper
• Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation.

  2000cited by this paper
• Definitive functional evidence for a tumor suppressor gene on human chromosome 7q31.1 neighboring the Fra7G site

  2000cited by this paper
• Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis.

  2000cited by this paper
• Isolation and mapping of a human septin gene to a region on chromosome 17q, commonly deleted in sporadic epithelial ovarian tumors.

  2000cited by this paper
• BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

  2000cited by this paper
• Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers

  2000cited by this paper
• Accommodating haploinsufficient tumour suppressor genes in Knudson's model

  2000cited by this paper
• Allelic loss at SMAD4 in polyps from juvenile polyposis patients and use of fluorescence in situ hybridization to demonstrate clonal origin of the epithelium.

  2000cited by this paper
• Complementation of an hMSH2 defect in human colorectal carcinoma cells by human chromosome 2 transfer

  2000cited by this paper
• Laser capture microdissection in pathology.

  2000cited by this paper
• Germline mutations of the dpc4 gene in Korean juvenile polyposis patients

  2000cited by this paper
• Cell cycle regulatory gene abnormalities are important determinants of leukemogenesis and disease biology in adult acute lymphoblastic leukemia.

  2000cited by this paper
• Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.

  2000cited by this paper
• The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.

  2000cited by this paper
• PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1

  2000cited by this paper
• Genomic and expression analyses of alternatively spliced transcripts of the MLL septin-like fusion gene (MSF) that map to a 17q25 region of loss in breast and ovarian tumors.

  2000cited by this paper
• A human melanoma metastasis‐suppressor locus maps to 6q16.3‐q23

  2000cited by this paper
• Physical and transcriptional mapping of the 17p13.3 region that is frequently deleted in human cancer.

  2000cited by this paper
• Identification of a gene at 16q24.3 that restores cellular senescence in immortal mammary tumor cells

  1999cited by this paper
• Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.

  1999cited by this paper
• Identification of a Gene That Reverses the Immortal Phenotype of a Subset of Cells and Is a Member of a Novel Family of Transcription Factor-Like Genes

  1999cited by this paper
• Frequent 4‐bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients

  1999cited by this paper
• Suppression of tumorigenicity in human ovarian cancer cell lines is controlled by a 2 cM fragment in chromosomal region 6q24-q25

  1999cited by this paper
• High density synthetic oligonucleotide arrays

  1999cited by this paper
• Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells.

  1999cited by this paper
• RB1 gene mutations in retinoblastoma

  1999cited by this paper
• Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma.

  1999cited by this paper
• Gene amplification and overexpression of CDK4 in sporadic breast carcinomas is associated with high tumor cell proliferation.

  1999cited by this paper
• hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability.

  1999cited by this paper
• Functional roles of chromosomes 11 and 17 in the transformation of human breast epithelial cells in vitro.

  1999cited by this paper
• Amplification and Expression of Cyclin D Genes (CCND1 CCND2 and CCND3) in Human Malignant Gliomas

  1999cited by this paper
• Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene

  1999cited by this paper
• Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1‐13.2

  1999cited by this paper
• SMAD genes in juvenile polyposis

  1999cited by this paper
• Cancer-epigenetics comes of age

  1999cited by this paper
• Novel tumor suppressor locus in human chromosome region 3p14.2.

  1999cited by this paper
• The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.

  1999cited by this paper
• Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations.

  1999cited by this paper
• The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.

  1999cited by this paper
• Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas

  1998cited by this paper
• Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells.

  1998cited by this paper
• Alterations of the PPP2R1B gene in human lung and colon cancer.

  1998cited by this paper
• Cell cycle-related gene abnormalities and product expression in esophageal carcinoma.

  1998cited by this paper
• Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.

  1998cited by this paper
• Mouse models in tumor suppression

  1998cited by this paper
• Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.

  1998cited by this paper
• Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer.

  1998cited by this paper
• Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): localization to 3p21.3 and loss of heterozygosity in lung and oral cancers.

  1998cited by this paper
• Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors.

  1998cited by this paper
• Evidence for a putative telomerase repressor gene in the 3p14.2–p21.1 region

  1998cited by this paper
• Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.

  1998cited by this paper
• Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.

  1998cited by this paper

• STRs: Ancient Architectures of the Genome beyond the Sequence

  2021cites this paper
• Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.

  2017cites this paper
• Attenuated RND1 Expression Confers Malignant Phenotype and Predicts Poor Prognosis in Hepatocellular Carcinoma

  2017cites this paper
• Clinical Significance of FANCD 2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma

  2017cites this paper
• Loss of Heterozygosity

  2016cites this paper
• Loss of heterozygosity: what is it good for?

  2015cites this paper
• Canine Mammary Tumours Are Affected by Frequent Copy Number Aberrations, including Amplification of MYC and Loss of PTEN

  2015cites this paper
• An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer

  2012influential citation
• STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas

  2012cites this paper
• Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior

  2011cites this paper
• Profiling the cancer genome.

  2010cites this paper
• Genetic and gene expression analysis of nasopharyngeal carcinoma (NPC)

  2010cites this paper
• Are there any more ovarian tumor suppressor genes? A new perspective using ultra high‐resolution copy number and loss of heterozygosity analysis

  2009cites this paper
• Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection.

  2008cites this paper
• Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes

  2008influential citation
• Allergies: Their Role in Cancer Prevention

  2008cites this paper
• THE QUARTERLY REVIEW of Biology ALLERGIES: THEIR ROLE IN CANCER PREVENTION

  2008cites this paper
• Single nucleotide polymorphism array analysis of cancer

  2007cites this paper
• Computational aspects of DNA copy number measurement

  2007influential citation
• The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer.

  2007cites this paper
• Microsatellites and their genomic distribution, evolution, function and applications : A review with special reference to fish genetics

  2006cites this paper
• Genetic Changes in Ovarian Cancer

  2005cites this paper
• An epigenetic approach for identifying novel tumor associated genes from regions of loss of heterozygosity in human neoplasias.

  2005cites this paper
• Alterations of cell signaling pathways in pancreatic cancer.

  2004cites this paper